AbbVie
ABBV
3,504 hedge funds and large institutions have $250B invested in AbbVie in 2024 Q3 according to their latest regulatory filings, with 242 funds opening new positions, 1,427 increasing their positions, 1,394 reducing their positions, and 71 closing their positions.
241% more first-time investments, than exits
New positions opened: 242 | Existing positions closed: 71
27% more call options, than puts
Call options by funds: $3.65B | Put options by funds: $2.87B
18% more funds holding in top 10
Funds holding in top 10: 177 → 208 (+31)
15% more capital invested
Capital invested by funds: $217B → $250B (+$32.8B)
4% more funds holding
Funds holding: 3,370 → 3,504 (+134)
2% more repeat investments, than reductions
Existing positions increased: 1,427 | Existing positions reduced: 1,394
0.01% more ownership
Funds ownership: 71.67% → 71.69% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$964M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$388M |
| 3 |
Morgan Stanley
New York
|
+$275M |
| 4 |
State Street
Boston,
Massachusetts
|
+$237M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$184M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$388M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$339M |
| 3 |
APG Asset Management
Amsterdam,
Netherlands
|
-$264M |
| 4 |
Janus Henderson Group
London,
|
-$262M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$246M |
ABBV Hedge Fund Activity: Q3 2024 in Review
3,504 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2024, worth a combined $250B — up 15% from $217B a quarter earlier.
Buyers outnumbered sellers: 242 funds opened new ABBV positions and 71 closed out — a net gain of 171 holders — while 1,427 added to existing stakes and 1,394 trimmed.
The largest buyer was Capital World Investors, adding an estimated $964M. The largest seller was Franklin Resources, cutting an estimated $388M.
- 3,504 institutional investors held AbbVie (ABBV) as of Q3 2024, up from 3,370 in Q2 2024.
- Funds reported $250B of AbbVie stock for Q3 2024, up 15% quarter-over-quarter.
- 242 funds opened new AbbVie positions in Q3 2024 and 71 closed out, a net change of +171 holders.
- The largest AbbVie buyer in Q3 2024 was Capital World Investors, an estimated $964M added.
- The largest AbbVie seller in Q3 2024 was Franklin Resources, an estimated $388M sold.
Based on aggregated 13F filings for Q3 2024.